Trial Profile
A Randomized, Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Control in Patients Transitioning From Chronic Kidney Disease Stage 4 Through Dialysis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2014
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary) ; Darbepoetin alfa; Epoetin alfa
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 30 Sep 2014 New trial record